ADCs & Engineered Antibodies Beacon
Make Faster, Better Drug Development Decisions
Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies combined with the most accurate and comprehensive data, provide our customers with unparalleled visibility of the drug and trial landscape.
ADC Landscape Review
The Beacon ADC 2024 Landscape Review is your definitive guide to the latest advancements in antibody-drug conjugates. Explore novel payloads, targets, and key clinical and commercial trends.

Bispecific Landscape Review
The Review delivers critical insights into the latest innovations, from novel therapeutic formats to strategic industry moves. Explore groundbreaking clinical developments, commercial trends, and the evolving regulatory environment shaping the future of bispecifics.

Checkpoint Landscape Review
Download this critical review to gain an in-depth analysis of the evolving checkpoint therapy landscape. With growing competition and strategic investment shifts, stay at the forefront of information in the space with Beacon’s 2024 Landscape Review.

Cytokine Landscape Review
Download the 2024 Cytokine Review for unparalleled information on the evolving cytokine landscape, from the rise of advanced modalities like bispecific antibodies and CAR-T cells to shifting clinical and regulatory trends. Gain insights into late-stage trial activity, recent approvals, and the changing investment climate shaping the future of cytokine therapies.

ADCs & Engineered Antibodies Beacon Team
ADCs & Engineered Antibodies Products by Type
CONTACT US
Get in touch
We speak to hundreds of biopharmaceutical experts from industry and academia every day. We would love for you to be one of them. Contact us to discover how our events can accelerate your drug development.
Standard Form - ADCs & Engineered Antibodies
"*" indicates required fields